Monday, December 1, 2008 - 8:47PM EST

Clinical Trials

11. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

Author
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Moller P; Weitzel J; Sun P; Narod SA;
Institution
Lawrence Bloomberg Faculty of Nursing, University of Toronto, Canada.
Journal
J Clin Oncol. 2008 Mar 1;26(7):1093-7. Epub 2008 Jan 14.
Abstract URL
Click here to view abstract

12. Information and decision making: patients' needs and experiences in the course of breast cancer treatment.

Author
Vogel BA; Bengel J; Helmes AW;
Institution
Department of Rehabilitation Psychology and Psychotherapy, University of Freiburg, Germany. vogel@psychologie.uni-freiburg.de
Journal
Patient Educ Couns. 2008 Apr;71(1):79-85. Epub 2008 Jan 8.
Abstract URL
Click here to view abstract

13. Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer.

Author
Saji S; Toi M; Morita S; Iwata H; Ito Y; Ohno S; Kobayashi T; Hozumi Y; Sakamoto J;
Institution
Department of Surgery and Breast Oncology, Division of Clinical Trials and Research, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Journal
Oncology. 2007;72(5-6):330-7. Epub 2008 Jan 12.
Abstract URL
Click here to view abstract

14. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).

Author
Holmes DR; Baum M; Joseph D;
Institution
American College of Surgeon, 55 East Erie Street, Chicago, IL 60611-2797, USA. dholmes@usc.edu
Journal
Am J Surg. 2007 Oct;194(4):507-10.
Abstract URL
Click here to view abstract

15. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.

Author
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M;
Institution
Department of Surgery, William Beaumont Hospital, 3577 W. 13 Mile Rd, Suite 201, Beaumont Cancer Center, Royal Oak, MI 48073, USA. pbenitez@beaumont.edu
Journal
Am J Surg. 2007 Oct;194(4):456-62.
Abstract URL
Click here to view abstract

16. Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients.

Author
Benediktsson KP; Perbeck L;
Institution
Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden. krispetben@hotmail.com
Journal
Eur J Surg Oncol. 2008 Feb;34(2):143-8. Epub 2007 Aug 20.
Abstract URL
Click here to view abstract

17. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.

Author
Spiegel D; Butler LD; Giese-Davis J; Koopman C; Miller E; DiMiceli S; Classen CC; Fobair P; Carlson RW; Kraemer HC;
Institution
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-5718, USA. dspiegel@stanford.edu
Journal
Cancer. 2007 Sep 1;110(5):1130-8.
Abstract URL
Click here to view abstract

18. Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.

Author
Masuda N; Taguchi T; Nakayama T; Shiba E; Watatani M; Kurebayashi J; Takatsuka Y; Sakamoto J; Noguchi S;
Institution
Department of Surgery, Breast Oncology Group, Osaka National Hospital, 2-1-14, Honenzaka, Chuou-ku, Osaka city, Osaka 540-0006, Japan. nmasuda@alpha.ocn.ne.jp
Journal
Cancer Chemother Pharmacol. 2008 May;61(6):989-95. Epub 2007 Jul 20.
Abstract URL
Click here to view abstract

19. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.

Author
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Institution
Department of Surgery, School of Medicine, Cardiff University, Cardiff, United Kingdom. goyala@cf.ac.uk
Journal
Ann Surg Oncol. 2008 Jan;15(1):262-7. Epub 2007 Sep 19.
Abstract URL
Click here to view abstract

20. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results.

Author
Cuttino LW; Keisch M; Jenrette JM; Dragun AE; Prestidge BR; Quiet CA; Vicini FA; Rescigno J; Wazer DE; Kaufman SA; Ramakrishnan VR; Patel R; Arthur DW;
Institution
Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA 23298-0058, USA. lcuttino@mcvh-vcu.edu
Journal
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):107-14. Epub 2007 Nov 26.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8